Immunotherapy Tablets For Dust Mite Allergy Reduce Asthma Risk
Are allergy shots going out of favor. This is good news for patients and bad news for allergist who make most of their income out of allergy shots for at least 3 years. The tablets are much more convenient however the price might be very high!
In 2014, the Food and Drug Administration approved Oralair for grass allergies. It was the first sublingual allergy immunotherapy tablet approved for use in the United States. It then approved Grastek, also for grass allergies, and Ragwitek, for ragweed allergies.
Immunotherapy tablets for dust mite allergy reduced the risk of an attack in people with moderate to severe asthma. The results were published in JAMA (Journal of the American Medical Association).
Allergy shots that inject an allergen extract under the skin have long been used to treat asthma, allergies and eczema, but they’re a pain in many ways. So patients and doctors have been eager to see if the tablets could work as well to tame the runaway immune response that causes allergic symptoms.